Status:

COMPLETED

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

Lead Sponsor:

Vyne Therapeutics Inc.

Conditions:

Acne Vulgaris

Eligibility:

All Genders

9+ years

Phase:

PHASE3

Brief Summary

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris (Study FX...

Detailed Description

This is a randomized, multicenter, double-blind, vehicle-controlled, 2 arm study to evaluate the safety and efficacy over 12 weeks of FMX101 topical foam containing 4% minocycline compared to vehicle ...

Eligibility Criteria

Inclusion

  • Has facial acne vulgaris with:
  • 20 to 50 inflammatory lesions (papules, pustules, and nodules)
  • 25 to 100 non-inflammatory lesions (open and closed comedones)
  • No more than 2 nodules on the face
  • IGA score of moderate (3) to severe (4)
  • Willing to use only the supplied non-medicated cleanser (Cetaphil Gentle Skin Cleanser) and to refrain from use of any other acne medication, medicated cleanser, excessive sun exposure, and tanning booths for the duration of the study.

Exclusion

  • Acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne), or any dermatological condition of the face or facial hair (eg, beard, sideburns, mustache) that could interfere with the clinical evaluations.
  • Sunburn on the face.

Key Trial Info

Start Date :

July 17 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 4 2018

Estimated Enrollment :

1488 Patients enrolled

Trial Details

Trial ID

NCT03271021

Start Date

July 17 2017

End Date

September 4 2018

Last Update

January 18 2022

Active Locations (98)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 25 (98 locations)

1

Foamix Investigational Site #376

Phoenix, Arizona, United States, 85023

2

Foamix Investigational Site #395

Tucson, Arizona, United States, 85712

3

Foamix Investigational Site #315

Bryant, Arkansas, United States, 72022

4

Foamix Investigational Site #340

Fort Smith, Arkansas, United States, 72916